Ann Lee is Head of Cell Therapy Development and Operations at Celgene, which acquired Juno Therapeutics where she was Executive Vice President of Technical Operations. She was previously Senior Vice President at Genentech, and Head of Global Technical Development at Roche, responsible for delivering the R&D pipeline and providing technical support for all commercial products. Prior to that, at Merck, she was Vice President of Chemical Technology and Engineering in the Manufacturing Div., overseeing process engineering and technical operations at 10 chemical sites around the world. She also had project leadership and functional leadership roles in the Merck Research Labs working on vaccines and bioprocess development. She studied chemical engineering at Cornell (BSChemE) and Yale (PhD). She is a member of the American Institute of Medical and Biological Engineering, the National Academy of Engineering, and the American Academy of Arts and Sciences. Over the course of her career, she has contributed to the commercialization of 23 new vaccines and medicines.
Lee holds a Bachelor of Science in chemical engineering from Cornell University, and a Ph.D. in biochemical engineering/molecular biophysics and biochemistry from Yale University. She has over 35 scientific publications and numerous patents. She was elected to the National Academy of Engineering in 2007, and is a member of the American Institute of Chemical Engineers, American Chemical Society, Society of Women Engineers, Sigma Xi, a Fellow of the American Institute of Medical and Biological Engineering. She serves on various academic and scientific advisory boards. She received the 2010 Corporate Innovation Award on behalf of Genentech awarded by the AIChE. She was named as one of 150 most influential women in Bay Area Business for 2011, and awarded the 2012 Genentech Women Professionals’ Leadership Award. She was formerly Associate Editor of Biotechnology and Applied Biochemistry, is an organizer of numerous scientific conferences and an invited lecturer at various meetings and universities. She is actively involved in various professional society service activities, serves as executive sponsor to various Genentech diversity groups, and is involved in mentoring boys and girls in science.